The company 23andMe, known for its at-home DNA testing kit service, possesses one of the largest banks of human genetic data on the planet. 

To further their mission of helping people benefit from genetic insights, they announced earlier this week that they have developed a new drug targeting psoriasis, using DNA information obtained in their tests. 

23andMe has sold over 10 million DNA testing kits to date. More than 80% of their customers have agreed to their data being used by scientists trying to understand the causes of diseases and how best to treat them.

This move represents a shift in the traditional pharmaceutical development process.

Most people can only focus on the money that will be made and how it will be distributed.

However, the real story here is that genetic insight is going to lead to better methods of fighting disease. 

Know someone whose used 23andMe? Share this!